HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome.

Abstract
We have investigated the involvement of the MAPK signaling pathway in increased androgen biosynthesis and CYP17 gene expression in women with polycystic ovary syndrome (PCOS). A comparison of MAPK kinase (MEK1/2) and ERK1/2 phosphorylation in propagated normal and PCOS theca cells, revealed that MEK1/2 phosphorylation was decreased more than 70%, and ERK1/2 phosphorylation was reduced 50% in PCOS cells as compared with normal cells. Infection with dominant-negative MEK1 increased CYP17 mRNA and dehydroepiandrosterone (DHEA) abundance, whereas constitutively active MEK1 reduced DHEA production and CYP17 mRNA abundance. Similarly, the MEK inhibitor, PD98059, increased CYP17 mRNA accumulation and CYP17 promoter activity to levels observed in PCOS cells. Remarkably, in theca cells maintained in the complete absence of insulin, ERK1/2 phosphorylation was decreased in PCOS theca cells as compared with normal theca cells, and CYP17 mRNA and DHEA synthesis were increased in PCOS theca cells. These studies demonstrate that in PCOS cells reduced levels of activated MEK1/2 and ERK1/2 are correlated with increased androgen production, irrespective of the insulin concentration. These findings implicate alterations in the MAPK pathway in the pathogenesis of excessive ovarian androgen production in PCOS.
AuthorsVelen L Nelson-Degrave, Jessica K Wickenheisser, Karen L Hendricks, Tomoichiro Asano, Midori Fujishiro, Richard S Legro, Scot R Kimball, Jerome F Strauss 3rd, Jan M McAllister
JournalMolecular endocrinology (Baltimore, Md.) (Mol Endocrinol) Vol. 19 Issue 2 Pg. 379-90 (Feb 2005) ISSN: 0888-8809 [Print] United States
PMID15514033 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Androgens
  • Enzyme Inhibitors
  • Flavonoids
  • Insulin
  • RNA, Messenger
  • Steroids
  • Dehydroepiandrosterone
  • Steroid 17-alpha-Hydroxylase
  • Extracellular Signal-Regulated MAP Kinases
  • Mitogen-Activated Protein Kinase Kinases
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
Topics
  • Adenoviridae (metabolism)
  • Androgens (biosynthesis)
  • Animals
  • Blotting, Western
  • Cell Line
  • Cells, Cultured
  • Dehydroepiandrosterone (metabolism)
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors (pharmacology)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Female
  • Flavonoids (pharmacology)
  • Genes, Dominant
  • Humans
  • Insulin (metabolism)
  • Lac Operon
  • Mitogen-Activated Protein Kinase Kinases (metabolism)
  • Mutation
  • Ovary (metabolism)
  • Phosphorylation
  • Polycystic Ovary Syndrome (metabolism)
  • Promoter Regions, Genetic
  • RNA, Messenger (metabolism)
  • Steroid 17-alpha-Hydroxylase (biosynthesis, metabolism)
  • Steroids (metabolism)
  • Theca Cells (metabolism)
  • Time Factors
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: